‘Doubtful debt’ impacts Sigma earnings

Sigma has pointed to “doubtful debt” relating to one pharmacy group as having impacted its earnings before interest and tax during the last financial year Sigma Pharmaceuticals says it will announce its results for the full year ending 31 January 2017 on 23 March, but that it expects its underlying EBIT to be just over

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Forum: Show us ya scripts on file
Next QUM network launches in SEQ, NSW